The molecular basis of opioid receptor function.

Area of Science:

• Neuropharmacology
• Molecular Biology
• Biochemistry

Background:

• Opioid drugs exert diverse effects mediated by at least three receptor subtypes: mu, delta, and kappa.
• Distinct pharmacological profiles and ligand selectivities suggest these opioid receptors are separate molecular entities.
• Previous studies indicated the existence of these subtypes, but direct molecular characterization was ongoing.

Purpose of the Study:

• To provide molecular confirmation for the existence of distinct mu, delta, and kappa opioid receptor subtypes.
• To characterize the purified subunits of these opioid receptors.
• To elucidate the G-protein coupling and signaling mechanisms of different opioid receptor subtypes.

Main Methods:

• Purification and affinity labeling of opioid receptor subunits from neuronal cell lines (NG108-15) and brain tissue (bovine striatum, guinea pig brain).
• Characterization of purified receptor subunits using techniques like SDS-PAGE and immunoblotting with specific antibodies.
• Biochemical and electrophysiological experiments to investigate opioid receptor coupling to G-proteins (Gi, Gk) and downstream signaling pathways (adenylyl cyclase, ion channels).

Main Results:

• The delta-opioid receptor was purified as a 58,000 Mr glycoprotein subunit.
• The mu-opioid receptor was purified as a 65,000 Mr glycoprotein from bovine striatum, though other studies suggest 58,000 Mr.
• Evidence confirmed opioid receptor coupling to Gi, inhibiting adenylyl cyclase, and coupling to G-proteins mediating potassium and calcium channel activity.

Conclusions:

• Molecular purification and characterization provide strong evidence for distinct mu, delta, and kappa opioid receptor subtypes.
• Opioid receptors are G-protein coupled receptors, with specific subtypes linking to distinct intracellular signaling pathways.
• Future molecular cloning will define the primary structure of opioid receptors and potentially reveal novel subtypes.